Cited by 71Metabolism, Diabetes, and CancerNatural Antidiabetic Agents StudiesPeroxisome Proliferator-Activated Receptors

Discovery of MK-8722: A systemic, direct pan-activator of amp-activated protein kinase

Open access
Feng, Danqing, Biftu, Tesfaye, Romero, F. Anthony, Kekec, Ahmet, Dropinski, James, Kassick, Andrew, Xu, Shiyao, Kurtz, Marc M. +12 more·2018·ACS Medicinal Chemistry Letters

Abstract

5'-Adenosine monophosphate-activated protein kinase (AMPK) is a key regulator of mammalian energy homeostasis and has been implicated in mediating many of the beneficial effects of exercise and weight loss including lipid and glucose trafficking. As such, the enzyme has long been of interest as a target for the treatment of Type 2 Diabetes Mellitus. We describe the optimization of β1-selective, liver-targeted AMPK activators and their evolution into systemic pan-activators capable of acutely lowering glucose in mouse models. Identifying surrogates for the key acid moiety in early generation compounds proved essential in improving β2-activation and in balancing improvements in plasma unbound fraction while avoiding liver sequestration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsmedchemlett.7b00417

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some pharmacological AMPK activators, such as MK-8722, cause cardiac hypertrophy, which is considered the main side effect of pharmacological pan-AMPK activation.

    “However, some pharmacological AMPK activators, such as MK-8722 [203], cause cardiac hypertrophy, which is considered the main side effect of pharmacological pan-AMPK activation [17].”

    From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [203]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Federation I. D.IDF Diabetes Atlas, 7th ed.; International Diabetes Federation: Belgium, 2015. [Google Scholar]

Cited by

Sorted by citations

Authors
Feng, D., Biftu, T., Romero, F. A., Kekec, A., Dropinski, J., Kassick, A., Xu, S., Kurtz, M. M., Gollapudi, A., Shao, Q., Yang, X., Lu, K., Zhou, G., Kemp, D., Myers, R. W., Guan, H.-P., Trujillo, M. E., Li, C., Weber, A., & Sebhat, I. K.
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author
Sebhat, Iyassu K.
Venue
ACS Medicinal Chemistry Letters
Published
2017-12-08
Volume
9
Issue
1
Pages
39-44
ISSN
1948-5875 (ISSN-L)
OpenAlex
W2773377322
Cited by
64
References
18
Citations by year
2026: 11 · 2025: 13 · 2024: 6 · 2023: 11 · 2022: 7 · 2021: 3 · 2020: 6 · 2019: 3 · 2018: 4
FWCI
1.79
Type
journal article
Language
en
Open access
Locations
  • ACS Medicinal Chemistry Letters (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
AMPK, AMPK activators, type 2 diabetes, blood glucose reduction, systemic drug delivery, energy homeostasis, structure-activity optimization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review